Dr. Corales is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2501 W Long Lake Rd
West Bloomfield, MI 48323Phone+1 585-747-3717
Summary
- Dr. Roberto Corales is an infectious disease specialist in Rochester, NY and is affiliated with multiple hospitals in the area, including Highland Hospital and Strong Memorial Hospital of the University of Rochester. He received his medical degree from Michigan State University College of Osteopathic Medicine and has been in practice 25 years. He specializes in hiv/aids medicine.
Education & Training
- St. John Fisher CollegeCertificate, Nonprofit Management Center for Community Engagement, 2007 - 2008
- Cleveland Clinic FoundationFellowship, Infectious Disease, 1997 - 2000
- Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 1993 - 1997
- New York-Presbyterian Brooklyn Methodist HospitalInternship, Osteopathic Internship, 1992 - 1993
- Michigan State University College of Osteopathic MedicineClass of 1992
- Eastern Michigan UniversityB.A., Major in French Language and Literature, Minor in Performance Dance and Biology, Cum Laude, 1980 - 1985
- Eastern Michigan UniversityB.S., Chemistry, Cum Laude
Certifications & Licensure
- NY State License 1995 - 2025
Awards, Honors, & Recognition
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2015
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015
- Linda Laubenstein HIV Clinical Excellence Award NYS Department of Health, AIDS Institute, 2011
- Join now to see all
Clinical Trials
- Long-term Observational Study in HIV Subjects Exposed to EGRIFTA® Start of enrollment: 2013 Feb 01
- FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir Start of enrollment: 2013 Apr 25
- Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART Start of enrollment: 2014 Dec 30
Publications & Presentations
PubMed
- 37 citationsRaltegravir (MK-0518): a novel integrase inhibitor for the treatment of HIV infection.Mary Anker, Roberto Corales
Expert Opinion on Investigational Drugs. 2008-01-01 - 97 citationsHospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV InfectionTrevor A. Crowell, Kelly A. Gebo, Joel N. Blankson, P. Todd Korthuis, Baligh R. Yehia
The Journal of Infectious Diseases. 2015-06-01 - 16 citationsBridging the digital divide in HIV care: a pilot study of an iPod personal health record.Amneris E. Luque, Roberto Corales, Richard J. Fowler, Jamie DiMarco, Adjuah van Keken
Journal of the International Association of Providers of AIDS Care. 2013-03-01
Journal Articles
- Bridging the Digital Divide in HIV Care: A Pilot Study of an iPod Personal Health vLuque AE, Corales RB, Fowler EJ, DiMarco J, van Keken A, Winters P, Keefer MC, Fiscella K, Journal of the International Association of Physicians in AIDS Care, 1/10/2012
- Anal cancer screening in HIV-infected patients: is it time to screen them all?Mallari AO, Schwartz TM, Luque AE, Polashenski PS, Rauh SM, Corales RB, Dis Colon Rectum, 1/1/2012
- Efficacy and safety of switching suppressed patients with elevated trigylcerides from lopinavir/ritonavir or fosamprenavir/ritonavir to atazanavir/ritonavir or darunav...Skiest DJ, Cohen C, Homayoon K, DeJesus E, Vanig T, Tribble M, Petroll A, Olivet H, Mounzer K, Corales R, Rhame F, Bellos N, Garb J, HIV & AIDS Review, 1/1/2012
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- PrEP in the Real World: Implementation of PrEP in a medium-sized city Community Health ClinicCorales R, Holt S, Chen S-R, Zuppelli A, Ritzler J, Roberts J, Schaefer W, Smith K, Mancenido M, Valenti,W, IAS Conference, 1/22/2015
- Gender-specific Analysis of Risk Factors for the Development of Anal Cancer Among HIV-Infected PatientsMallari AO, Schwartz TM, Gorospe E, Luque AE, Rauh SM, Corales RB, Am J Gastroenterol, 1/1/2012
- Anal Pap versus High- Resolution Anoscopy in the Screening for High-Grade Anal Dysplasia Among HIV-Positive Patients: Are We Using the Best Screening Tool?Mallari, A, Schwartz, T, Gorospe E, Luque A, Rauh S, Corales R, Digestive Disease Week, Chicago, IL, 1/10/2011
- Join now to see all
Other
- Typhoid FeverBrusch JL, Garvey T, Corales R, Schmitt SK, eMedicine
www.emedicine.com/med/topic2331.htm
1/3/2008 - Novel Advances in Second Line HIV TherapyCorales RB, O Brien William, Institute for Medicine (PMI) and M2 Communications
1/1/2005 - Nucleoside and Nucleotide Reverse Transcriptase Inhibitors in the Treatment of HIV: Focus on SafetyLichtenstein, KA, Corales RB
1/30/2003
Research History
- Site Leader, Clinical Research Site, AIDS Clinical Trials Group (ACTG)2004 - 2015
- Principal Investigator, Trillium Health (previously AIDS Care)2000 - 2015
Professional Memberships
- Member
- Member
- American Academy of HIV MedicineAAHIVS
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: